Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

NeoStem Provides Results for 2010 and an Update on Recent Activities

April 1, 2011 By Bio-Medicine.Org

NEW YORK, April 1, 2011 /PRNewswire/ — NeoStem, Inc. (NYSE
Amex:
NBS) (“NeoStem” or the “Company”), an international
biopharmaceutical company with operations in the U.S. and China, is
today providing unaudited results for 2010 and an update of recent
activities:

Revenues for the year ended December 31, 2010 were $69.8 million
compared with $11.6 million for 2009.  2010 was the first full
year that results for the Company’s 51% owned subsidiary, Suzhou
Erye Pharmaceutical Co. Ltd. (“Erye”), were included in the
Company’s results.   For the year ended December 31, 2010,
revenues increased 13% over the 2009 pro forma revenue of $61.7
million.   For the year ended December 31, 2010, the Company
invested $16.4 million in capital expenditures primarily related to
the construction of a new pharmaceutical manufacturing facility at
Erye. Net cash used in operating activities for the year ended
December 31, 2010 was $8.5 million compared to $8.4 million for the
year ended December 31, 2009. Cash and cash equivalents at December
31, 2010 were $15.6 million.

The Company’s Annual Report on Form 10-K for 2010 containing
full audited financial statements for 2010 is expected to be filed
next week.

NeoStem continues to focus on revenue drivers which can be seen
by the January 2011 acquisition of Progenitor Cell Therapy, LLC
(“PCT”) which generates revenues in the US from the manufacturing,
development and storage of cells and cell therapies.  The
Company views this acquisition as a foundation to achieve its
strategic mission of capturing the paradigm shift to cell therapy.
 While NeoStem’s origins began in the adult stem cell therapy,
collection and storage service business, the PCT acquisition begins
a new dimension in the Company’s business model.  NeoStem
today, with 85 US based employees, brings to bear

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech